🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with france ansm? Page 4

Has anyone dealt with france ansm?

mia_MS2 Wed, Jul 2, 2025 at 6:21 PM 27 replies 1,773 viewsPage 4 of 6
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Jul 4, 2025 at 4:13 PM#16
TrialTracker_MD said:
If two explanations both fit, the useful question is which one predicts something the other does not.

This is my experience too, for whatever a second data point is worth.

43 18julia.endo, JessicaM_2024, TomFromTexas and 40 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jul 4, 2025 at 9:44 PM#17

From the other side of the consultation, briefly. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

42 17traveltech_sara, AttorneyGrant, DebRD_ATL and 39 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jul 5, 2025 at 3:15 AM#18
Dr.PulmRoch said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

Mine went the same way, slower.

41 16Dr.EndoIndy, tom_AK, josh_phd_bmore and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Jul 5, 2025 at 8:46 AM#19
Dr.PulmRoch said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

Coming at Dr.PulmRoch’s question from a different direction. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Happy to go further on any of that.

40 15TirzTom, TrialTracker_MD, JennaRN and 37 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jul 5, 2025 at 2:17 PM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. No action needed from anybody.

Last edited: Jul 5, 2025 at 4:17 PM
18 18PurityPaulOR, MaxMetOK, MounjBrad and 15 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register